News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
York Charles N II
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2023 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 955 shares
@ $13.1223, valued at
$12.5k
Exercised 1,375 restricted stock units
@ $0
Exercised 2,250 restricted stock units
@ $0 |
|
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/21/2023 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 9,377 shares
@ $20.0267, valued at
$187.8k
|
|
| 01/23/2023 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $22.7523, valued at
$227.5k
|
|
| 01/19/2023 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Granted 116,000 options to buy
@ $20.87, valued at
$2.4M
Granted 36,000 restricted stock units
@ $0 |
|
| 11/22/2022 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 9,700 shares
@ $20.7374, valued at
$201.2k
Sold 300 shares
@ $21.39, valued at
$6.4k
|
|
| 11/17/2022 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 430 shares
@ $21.4598, valued at
$9.2k
Exercised 1,375 restricted stock units
@ $0 |
|
| 11/03/2022 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $20.0313, valued at
$200.3k
|
|
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2022 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 8,606 shares
@ $23.1593, valued at
$199.3k
Sold 1,394 shares
@ $23.7987, valued at
$33.2k
|
|
| 08/17/2022 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 1,089 shares
@ $24.31, valued at
$26.5k
Exercised 4,125 restricted stock units
@ $0 |
|
| 08/05/2022 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $20.0541, valued at
$200.5k
|
|
| 07/20/2022 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 2,500 shares
@ $20, valued at
$50k
|
|
| 07/12/2022 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 1,416 shares
@ $20, valued at
$28.3k
|
|
| 07/06/2022 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Sold 1,479 shares
@ $20, valued at
$29.6k
Sold 800 shares
@ $20, valued at
$16k
|
|
| 01/20/2022 |
4
| York Charles N II (COO, CFO and Secretary) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Granted 151,000 options to buy
@ $14.26, valued at
$2.2M
Granted 22,000 restricted stock units
@ $0 |
|
| 05/26/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2018 |
4
| York Charles N II (CFO and VP) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 92,100 options to buy
@ $6.31, valued at
$581.2k
|
|
| 12/05/2017 |
4
| York Charles N II (CFO and VP) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Bought 2,000 shares
@ $3.987, valued at
$8k
Bought 2,000 shares
@ $4.284, valued at
$8.6k
Bought 1,959 shares
@ $2.516, valued at
$4.9k
Bought 6,500 shares
@ $4.5931, valued at
$29.9k
Bought 3,259 shares
@ $4.9699, valued at
$16.2k
Bought 10,241 shares
@ $4.7554, valued at
$48.7k
|
|
| 08/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2017 |
4
| York Charles N II (CFO and VP) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $8.03, valued at
$722.7k
|
|
| 05/19/2016 |
4
| York Charles N II (CFO and VP) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $7.28, valued at
$400.4k
|
|
| 04/12/2016 |
4
| York Charles N II (CFO and VP) has filed a Form 4 on Aeglea BioTherapeutics, Inc.|
Txns:
| Converted 1,324 shares
@ $0
Converted 11,560 shares
@ $0
Converted 1,324 preferred shares
@ $0
Converted 9,523 preferred shares
@ $0
Converted 2,037 preferred shares
@ $0 |
|
| 04/06/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|